MWM
WST icon

Mission Wealth Management’s West Pharmaceutical WST Stock Holding History

Mission Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Buy
4,611
+150
+3% +$45.9K 0.02% 351
2026
Q1 		$1.12M Buy
4,461
+14
+0.3% +$3.48K 0.02% 310
2025
Q4 		$1.22M Sell
4,447
-77
-2% -$21.1K 0.02% 295
2025
Q3 		$1.19M Buy
4,524
+385
+9% +$93.6K 0.02% 303
2025
Q2 		$906K Buy
4,139
+95
+2% +$20.3K 0.02% 350
2025
Q1 		$905K Sell
4,044
-141
-3% -$38.9K 0.02% 330
2024
Q4 		$1.37M Sell
4,185
-64
-2% -$20.1K 0.03% 229
2024
Q3 		$1.28M Sell
4,249
-587
-12% -$180K 0.03% 242
2024
Q2 		$1.59M Buy
4,836
+463
+11% +$164K 0.04% 195
2024
Q1 		$1.73M Sell
4,373
-158
-3% -$58.4K 0.05% 202
2023
Q4 		$1.6M Buy
4,531
+114
+3% +$40.3K 0.05% 174
2023
Q3 		$1.66M Buy
4,417
+25
+0.6% +$9.67K 0.06% 152
2023
Q2 		$1.68M Sell
4,392
-40
-0.9% -$14.3K 0.06% 151
2023
Q1 		$1.54M Buy
4,432
+233
+6% +$68.1K 0.06% 163
2022
Q4 		$988K Buy
4,199
+237
+6% +$56.2K 0.05% 204
2022
Q3 		$975K Buy
3,962
+108
+3% +$32.9K 0.05% 192
2022
Q2 		$1.17M Buy
3,854
+714
+23% +$232K 0.06% 173
2022
Q1 		$1.29M Buy
3,140
+308
+11% +$121K 0.06% 164
2021
Q4 		$1.33M Sell
2,832
-52
-2% -$22.4K 0.06% 158
2021
Q3 		$1.22M Sell
2,884
-268
-9% -$113K 0.06% 155
2021
Q2 		$1.13M Sell
3,152
-43
-1% -$14.2K 0.06% 157
2021
Q1 		$900K Buy
3,195
+291
+10% +$83.3K 0.05% 160
2020
Q4 		$823K Buy
2,904
+461
+19% +$129K 0.05% 158
2020
Q3 		$672K Sell
2,443
-146
-6% -$38.6K 0.05% 163
2020
Q2 		$588K Buy
2,589
+69
+3% +$13.6K 0.05% 163
2020
Q1 		$384K Sell
2,520
-57
-2% -$8.77K 0.04% 184
2019
Q4 		$387K Buy
2,577
+39
+2% +$5.68K 0.04% 209
2019
Q3 		$360K Sell
2,538
-130
-5% -$17.9K 0.04% 202
2019
Q2 		$334K Buy
2,668
+62
+2% +$7.32K 0.04% 223
2019
Q1 		$287K Buy
2,606
+226
+9% +$23.5K 0.03% 233
2018
Q4 		$233K Buy
+2,380
New +$258K 0.03% 235

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mission Wealth Management's WST Position: Q2 2026 in Review

Mission Wealth Management increased its West Pharmaceutical (WST) stake by 3.4% in Q2 2026, buying an estimated $45.9K and bringing the position to 4,611 shares worth $1.66M. The position accounts for 0.02% of the portfolio, ranked #351.

Mission Wealth Management first reported a position in WST in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.73M in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Mission Wealth Management held 4,611 shares of West Pharmaceutical worth $1.66M as of Q2 2026.
  • Mission Wealth Management bought 150 West Pharmaceutical shares in Q2 2026, an estimated $45.9K.
  • West Pharmaceutical made up 0.02% of Mission Wealth Management's portfolio in Q2 2026, its #351 holding.
  • Mission Wealth Management first reported a position in West Pharmaceutical in Q4 2018 and has held it in 31 quarters since.
  • Mission Wealth Management's West Pharmaceutical position peaked at $1.73M in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Mission Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.